IXJ
iShares Global Healthcare ETF
iShares S&P Global Healthcare Sector Index Fund seeks investment results that correspond to the performance of the S&P Global Healthcare Index. The Fund uses a Representative Sampling strategy
Global
EQUITY
Passive
MANAGEMENT STYLE
$ 4.7 B
ASSETS UNDER MGMT
38 bp
EXPENSES
Fund Basics
| Inception date | Nov 13, 2001 |
| Regulation | Open-Ended Fund |
| Fund Website | link... |
| Distributions | Semi-annual |
| Currency | USD |
| Holdings Transparency | Full |
| Derivatives-based | No |
| Options available | Yes |
| Currency hedged | No |
| Fund of funds | No |
Top 10 Holdings
Complete list +
| ELI LILLY & CO | 11.7 % |
| JOHNSON & JOHNSON | 6.8 % |
| ABBVIE INC | 5.4 % |
| MERCK & CO. INC. | 4.2 % |
| UNITEDHEALTH GROUP INC | 4.2 % |
| ROCHE PS PAR AG | 3.9 % |
| NOVARTIS AG | 3.4 % |
| ASTRAZENECA PLC | 3.3 % |
| THERMO FISHER SCIENTIFIC INC | 2.9 % |
| AMGEN INC | 2.9 % |
Constituent Breakdown
| Number of holdings | 114 |
| Herfindahl-Hirschman Index | 325 |
| Wgt avg mkt cap (mns) | $298,869 |
| Large cap (>$10bn) | 95.0% |
| Mid cap ($2-10bn) | 0.7% |
| Small cap (<$2bn) | 0.0% |
| Developed mkts. | 94.5% |
| Emerging mkts. | 0.1% |
Sector Breakdown
Country Exposure
 |
UNITED STATES | 72.1 % |
 |
SWITZERLAND | 6.0 % |
 |
BRITAIN | 5.1 % |
 |
JAPAN | 3.5 % |
 |
DENMARK | 2.0 % |
 |
FRANCE | 1.9 % |
 |
IRELAND | 1.6 % |
 |
GERMANY | 1.3 % |
 |
AUSTRALIA | 1.1 % |
 |
NETHERLANDS | 0.9 % |
Historical Performance
Standardized Performance (as of 09/30/2026)
| YTD | 1 YR | 2 YR | 3 YR | 5 YR | 10 YR | 20 YR | Incep. | |
|---|---|---|---|---|---|---|---|---|
| Price Returns | 4.8% | 15.2% | 2.0% | 7.4% | 4.1% | 7.3% | 6.6% | 5.8% |
| Dividend Yield | 0.9% | 1.7% | 1.6% | 1.6% | 1.5% | 1.6% | 1.9% | 1.6% |
| Total Returns | 5.8% | 17.0% | 3.6% | 9.0% | 5.5% | 8.9% | 8.5% | 7.4% | Ann. Volatility | 16.1% | 15.6% | 15.9% | 14.4% | 14.7% | 15.8% | 17.0% | 16.9% |
Market Correlations
| versus... | Beta | R-squared |
| S&P 500 | 0.35 | 8% |
| MSCI EAFE | 0.43 | 19% |
| MSCI Emg Mkts | 0.06 | 1% |
Liquidity Measures
| Avg. volume (000) | 307 |
| ADV traded (mns) | $35 |
| Turnover | 0.7% |
| Avg. Bid/Ask (% of price) | 0.11% |
Technical Indicators
| 30d moving avg. (EMA) | $107.25 |
| Relative strength (RSI) | 64 |
| MACD/Signal | 2.30/1.87 |
| Bollinger Bands (Upper/Lower) | $114.60/$100.79 |
| Short interest (% of AUM) | 0.2% |
Distributions
Top Ten Comparable ETFs only shown here. For an extended list become an Individual or Professional subscriber. Start your FREE trial
Comparable ETFs Based on Overlap
| Ticker | Fund Name | Overlap vs. IXJ |
Expenses vs. IXJ |
ALTAR Score™ vs. IXJ |
|---|---|---|---|---|
| XLV | Health Care Select Sector SPDR | 73.7% | -30 bp | +0.2% |
| FHLC | Fidelity MSCI Health Care Index ETF | 73.7% | -30 bp | -0.9% |
| VHT | Vanguard Health Care ETF | 73.7% | -29 bp | -1.0% |
| IYH | iShares U.S. Healthcare ETF | 69.3% | -1 bp | -0.4% |
| PBPH | Portfolio Building Block World Pharma and Biotech Index ETF | 59.6% | -25 bp | +0.1% |
| JDOC | JPMorgan Healthcare Leaders ETF | 57.3% | +27 bp | -0.9% |
| HRTS | Tema Heart & Health ETF | 55.8% | +61 bp | -3.9% |
| GDOC | Goldman Sachs Future Health Care Equity ETF | 46.3% | +37 bp | -3.6% |
| RSPH | Invesco S&P 500 Equal Weight Health Care ETF | 46.1% | +2 bp | +0.5% |
| MEDX | Horizon Kinetics Medical ETF | 38.8% | +47 bp | -4.5% |
Risk and Returns: IXJ vs. Comps (1 YR)
Notes: Top 10 overlapping ETFs. Funds with insufficient history not shown. Some funds may overlap. Hover over data point for ticker symbol.
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Results & Estimates (USD)
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|---|---|
| Sales per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Earnings per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Dividends per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Book value per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- |
Return on Equity
Net Margins
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Valuation Metrics
| Fwd Est | 2025 | 2026 | 2027 | |
| Price-to-sales | --x | --x | --x | --x |
| Price-to-earnings | --x | --x | --x | --x |
| Price-to-cash flow | --x | --x | --x | --x |
| Price-to-growth | --x | --x | --x | --x |
| Price-to-book value | --x | --x | --x | --x |
| Yield | --% | --% | --x | --% |
Based on closing prices from 11/5/2026
Peer Group Comparison
Sample data. Subscribe for access.
Historical Valuation Trends Sample data. Subscribe for access.
Notes: Based on adjusted historical results for current fund constituents. May differ from results achieved by past fund constituents. Max P/E of 100x.
Some content on this tab for Individual & Professional subscribers only. Start your FREE trial
ETF Research Center Rating
5.7%
ALTAR SCORE™
64th
PERCENTILE
OVERWEIGHT
ETFRC RATING
There are 746 funds in the Global Equity category with an average
ALTAR Score™ of 4.8% and a standard deviation
of 2.6%. IXJ's ALTAR Score™ is approximately 0.4 standard
deviations above the category average. This places IXJ in the 64th percentile
among funds in the category.
Sell-Side Consensus
$120.99
PRICE TARGET
+7.2%
UPSIDE